Search

everythinglearnresearchcommunity

for

Search:↓

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Allopregnanolone and opioids together reduce stress hormone responses during pregnancy.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

Triphenylphosphine oxide can increase oil production and reduce inflammation in skin cells without affecting TRPM5.

Certain histamine receptors (H2R, H3R, H4R) have unique roles in treating skin diseases, with H2R helping with chronic urticaria and other conditions, H3R providing pain relief and allergy benefits, and H4R reducing inflammation and itchiness.

GnRH agonists can help manage recurrent priapism in sickle cell patients, but long-term safety is unclear.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

Thyrotropin-Releasing Hormone helps heal wounds in frog and human skin.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

PRP injections help relieve hip pain in most cases.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

TRPV3 channels are involved in skin processes and are affected by shear stress, influencing itch and mechanotransduction.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Phenylephrine may help prevent hair loss from pulling on the hair roots.

Thyroid receptor agonists may treat male pattern baldness without harmful side effects.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

OXTR agonists may promote hair growth and be effective for treating hair loss.

Naltrexone did not significantly reduce hair pulling but improved cognitive flexibility.

Tadalafil is effective for treating urinary symptoms in men with BPH.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

PTH-CBD agonists may help regrow hair after chemotherapy.

Delta opioid receptors help regulate touch sensation by reducing neurotransmitter release in the spinal cord.

Progesterone initially worsens but later reduces neuropathic pain in mice, through different mechanisms.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

TRP channels in the skin are important for sensation and health, and targeting them could help treat skin disorders.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Using a certain drug on the skin can help prevent hair loss caused by pulling on the hair.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.